Comprehensive RNAi screens for gene inactivations that extend lifespan have revealed that the most potent pathway for lifespan extension in C. elegans is the
daf-2 insulin-like signaling pathway. This pathway converges on the DAF-16 transcription factor which regulates a large number of genes. We sought to identify the full range of genes which are necessary for the long lifespan induction in a
daf-2 insulin signaling deficient mutant. To this end, we have identified genes whose inactivation shortened the lifespan of long-lived
daf-2 mutant animals through a systematic genome-wide RNAi screen of 18,681 clones. The primary screen identified 513 clones (2.6% of the genome) which suppressed the long lifespan of
daf-2 mutant animals to some extent. A more stringent lifespan, morphological, and reproductive analysis narrowed the 513 positives to 143 distinct gene inactivations which shorten lifespan and might function in aging. A major complication of any screen for shortened lifespan lies in discriminating aging genes from those that cause sickness upon inactivation. Thus any screen to study aging by shortening lifespan must have a means to distinguish aging from sickness. We classified gene inactivations which only shortened the lifespan of a
daf-2 mutant, and those which shortened the lifespan of control as well as a
daf-2 mutant. Additionally, analysis for each gene inactivation includes longitudinal scoring for changes in premature accumulation of aging pigments and changes in the expression of the DAF-16 target gene,
sod-3. This allowed a classification of those genes that accelerate the aging process versus those that show signs of poor health. Cumulative analysis of these phenotypes has allowed us to separated gene inactivations that accelerate aging from those which simply shorten lifespan and segregate the gene inactivations into refined classes. Highly represented in the gene inactivations that suppress lifespan extension in the
daf-2 mutant are genes that encode proteins that mediate endocytotic trafficking of membrane proteins to lysosomes. These gene inactivations act upstream of DAF-16 to suppress
sod-3. Inactivation of these genes may allow signaling to DAF-16 in the absence of insulin receptor signals, or may animate other signaling pathways that bypass the need for kinase input to DAF-16.